-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch

Dow Jones·11/05/2026 21:17:00

Please log in to view news